All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:
General domain:
Specific domain:
  1. Children in a playground

    Cost-effectiveness analysis of HPV vaccination of boys in Belgium

    KCE Reports 308 (2019) The vaccine for the human papilloma virus (HPV) which causes cervical cancer was introduced about ten years ago in Belgium, but only girls benefit from it. However, it is now established that this same virus is also involved in other cancers, including throat cancer. The recommendations have thus been reviewed and here, as in most western countries, it is now recommended to vaccinate boys too.

    https://kce.fgov.be/en/cost-effectiveness-analysis-of-hpv-vaccination-of-boys-in-belgium

  2. [Home Monitoring of Infants in Prevention of Sudden Infant Death Syndrome]

    KCE Reports 46 (2006)

    https://kce.fgov.be/en/publication/report/home-monitoring-of-infants-in-prevention-of-sudden-infant-death-syndrome

  3. [Screening for Colorectal Cancer : current evidence and budget impact for Belgium.]

    KCE Reports 45 (2006)

    https://kce.fgov.be/en/publication/report/screening-for-colorectal-cancer-current-evidence-and-budget-impact-for-belgium

  4. Cervical Cancer Screening and Human Papillomavirus (HPV) Testing

    KCE Reports 38 (2006) 2nd print (1st print, September 2006)

    https://kce.fgov.be/en/publication/report/cervical-cancer-screening-and-human-papillomavirus-hpv-testing

  5. Effects and costs of pneumococcal conjugate vaccination of Belgian children

    KCE Reports 33 (2006)

    https://kce.fgov.be/en/publication/report/effects-and-costs-of-pneumococcal-conjugate-vaccination-of-belgian-children

  6. [Prostate-specific-antigen (PSA) for the screening of prostate cancer]

    KCE Reports 31 (2006)

    https://kce.fgov.be/en/publication/report/prostate-specific-antigen-psa-for-the-screening-of-prostate-cancer

  7. Cost-effectiveness analysis of rotavirus vaccination of Belgian infants

    KCE Reports 54 (2007)

    https://kce.fgov.be/en/publication/report/cost-effectiveness-analysis-of-rotavirus-vaccination-of-belgian-infants

  8. HPV Vaccination for the Prevention of Cervical Cancer in Belgium: Health Technology Assessment

    KCE Reports 64 (2007)

    https://kce.fgov.be/en/publication/report/hpv-vaccination-for-the-prevention-of-cervical-cancer-in-belgium-health-technolog

  9. [Evaluation of universal and targeted hepatitis A vaccination programs in Belgium]

    KCE Reports 98 (2008)

    https://kce.fgov.be/en/publication/report/evaluation-of-universal-and-targeted-hepatitis-a-vaccination-programs-in-belgium

  10. [Cost-utility of Vaccination against Chickenpox in Children and against Herpes Zoster in Elderly in Belgium]

    KCE Reports 151 (2010)

    https://kce.fgov.be/en/publication/report/cost-utility-of-vaccination-against-chickenpox-in-children-and-against-herpes-zos

  11. Cost-effectiveness of 10- and 13-valent pneumococcal conjugate vaccines in childhood

    KCE Reports 155 (2011)

    https://kce.fgov.be/en/publication/report/cost-effectiveness-of-10-and-13-valent-pneumococcal-conjugate-vaccines-in-childho
  12. Hepatitis C: Screening en Preventie

    [Hepatitis C: Screening and Prevention]

    KCE Reports 173 (2012)

    https://kce.fgov.be/en/publication/report/hepatitis-c-screening-and-prevention

  13. Seasonal influenza vaccination: prioritizing children or other target groups? - Part II

    KCE Reports 204 (2013)

    https://kce.fgov.be/en/publication/report/seasonal-influenza-vaccination-prioritizing-children-or-other-target-groups-part-

  14. A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study

    KCE Reports 231 (2014)

    https://kce.fgov.be/en/publication/report/a-quadrivalent-vaccine-against-serogroup-b-meningococcal-disease-a-cost-effective

  15. Non-invasive markers of subclinical atherosclerosis for predicting a primary cardiovascular event: a rapid systematic review

    KCE Reports 244 (2015)

    https://kce.fgov.be/en/publication/report/non-invasive-markers-of-subclinical-atherosclerosis-for-predicting-a-primary-card
  16. CP241

    Cardiovascular pre-participation screening in young athletes

    KCE Reports 241 (2015) About 1 million young Belgians (14-34) are member of a sportsclub, and in addition, many others are practicing a sport outside the structure of a sport organization. As we all know, sport is very good for your health. But, unfortunately, but luckily very seldom, it can lead to a sudden death due to cardiac failure. The authorities already have made a lot of effort to limit the risk for sporters. But can we avoid this kind of shocking events by submitting young sporters, without heart complaints, to a systematic heart examination?

    https://kce.fgov.be/en/publication/report/cardiovascular-pre-participation-screening-in-young-athletes

  17. Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening

    KCE Reports 238 (2015)

    https://kce.fgov.be/en/publication/report/cervical-cancer-screening-program-and-human-papillomavirus-hpv-testing-part-ii-up

  18. Use of pneumococcal vaccines in the elderly: an economic evaluation

    KCE Reports 274 (2016) Supplementary material pdf fileR274_Supplementary-file_Univariate-sensitivity-analyses (13.95 MB) pdf fileR274_Supplementary-file_Sensitivity-analyses_PPV23-price (1.1 MB) pdf fileR274_Supplementary-file_Multivariate-sensitivity-analyses_Net-benefit-Box-plots (1.16 MB) pdf fileR274_Supplementary-file_Multivariate-sensitivity-analyses_CEAFs-and-CE-planes (58.74 MB) The results are also available in a searchable spreadsheet-database format for all scenario and sensitivity analyses.

    https://kce.fgov.be/en/publication/report/use-of-pneumococcal-vaccines-in-the-elderly-an-economic-evaluation